Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TARRYTOWN, N.Y., July 21, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company developing innovative ways to target and treat cancer, announced today that it...
-
TARRYTOWN, N.Y., July 7, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced details of its planned Phase 3 clinical trial for 1404, a developmental stage small...
-
TARRYTOWN, N.Y., June 24, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company developing innovative ways to target and treat cancer, announced today that Mark...
-
LAVAL, Quebec and TARRYTOWN, N.Y., June 3, 2015 (GLOBE NEWSWIRE) -- Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced...
-
TARRYTOWN, N.Y., May 27, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company developing innovative ways to target and treat prostate cancer, announced today...
-
TARRYTOWN, N.Y., May 6, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced results of operations for the first quarter ended March 31, 2015. "Our portfolio offers...
-
TARRYTOWN, N.Y., April 29, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat prostate cancer,...
-
TARRYTOWN, N.Y., April 8, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company developing innovative ways to target and treat prostate cancer, announced today...
-
TARRYTOWN, N.Y., April 7, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that its partner, FUJIFILM RI Pharma Co. Ltd. (Fuji), has dosed the first patient in...
-
TARRYTOWN, N.Y., March 16, 2015 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced its results of operations for the fourth quarter and year-end 2014. "We have...